Eginvit Multivitamin and Minerals with Ginseng Capsules

Multivitamin & Minerals with Ginseng Capsules



Each soft gelatin capsule contains:

Vitamin A (As Palmitate) BP 2000 IU

Vitamin B1 BP 1 mg

Vitamin B2 BP 1 mg

Vitamin B6 BP 1.34 mg

Vitamin B12 BP 1 mcg

Vitamin D3 BP 250 IU

Nicotinamide BP 8 mg

Calcium Pantothenate BP 1 mg

Ginseng 1 mg

Calcium (from Dibasic Calcium Phosphate BP) 190 mg

Phosphorus (from Dibasic Calcium Phosphate BP) 150 mg

Copper (from Copper Sulphate BP) 0.01 mg

Iodine (from Potassium Iodide BP) 0.0015 mg

Maganese (from Maganese Sulphate BP) 0.01 mg

Magnesium (from Magnesium Sulphate BP) 1 mg

Potassium (from Potassium Iodide & Potassium Sulphate BP) 1 mg

Zinc (from Zinc Sulphate BP) 0.15 mg

Iron (from Ferrous Sulphate BP) 5 mg

Excipients q.s.

Approved colours used in capsule shell.



Vitamins are organic substances which the body requires in small amounts for metabolism and is incapable of synthesizing, or doses not synthesize in sufficient quantity for its overall needs. They are not related chemically and differ in their physiological actions. Vitamins are assented dietary organic substances which the body cannot synthesize and are required in small amounts for metabolic processes. Vitamin E has antioxidant activity. It may also have anti-atherogenic, antithrombotic, anticoagulant neuroprotective, antiproliferative, immunomodulatory, cell membrane-stabilizing and antiviral actions.



Eginvit is balanced nutritional formulations of vitamins, minerals and Ginseng supplement for adults. Convalesance, debility, fatigue and reduced physical stamina.



Unless other prescribed by the physician, 1 capsule with liquid each day.



Eginvit contraindicated in individuals with known history of sensitivity or allergic reactions to this product or any of its ingredients. Multivitamin should not be used by patients with pre-existing hyperovitaminosis A and or/with impaired renal function, iron accumulation and iron utilization disorders, hypercalcemia or hypercalcuria and hypersensitivity to any ingredient of the product. The recommended dosage should not be exceeded and the medicine should not be taken together with other medicine and/or Dietary Supplements containing Vitamin A and/or Vitamin D in order to avoid overdosage of these vitamins.



Clinically significant drug interaction may occur on concomitant administration of Eginvit with some antibiotics, antimalarial and antidiabetic drugs. The effectiveness of some antibiotics e.g is the quinolones and anti malarial e.g Artemether/Lumenfantrine is been reduced. To avoid this interaction, Eginvit capsule should be taken two hours before or two hours after taking the drug. With antidiabetic drug, it causes a reduction in the sugar level, adequate monitoring is required. Drugs Iike NSAIDS, Anti hypertensive, Warfarin etc should not be administered concomitantly with Eginvit.



Increased Angina and/or Myocardial lnfarction Rarely, patients particularly those with severe obstructive coronary artery disease have developed documented increased frequency, duration have/or severity of angina or acute myocardial infarction on stating calcium channel blocker therapy of at the time of dosage increase. There is risk involved when administering Eginvit during pregnancy and lactation because it contains ginseng and this constituent have not been proven safe in pregnancy and lactation.



Multivitamin is well tolerated, in rare cases ,gastrointestinal disturbances (e.g. Constipation) may occur, but these generally do not necessitate withdrawal of therapy. Other, less serious side effects may be more likely to occur. Nausea, constipation, black stools and diarrhoea are among the most common. Taking multivitamins and minerals with food may decrease these side effects. Adverse effects have been reported with specific vitamins but generally at levels substantially higher than those in Eginvit Average Capasule doses in sensitive individuals or excessive dosage may cause nausea, skin rash, vomiting, diarrhea, precordial pain or flushing of the face and extremities. Adverse reaction with iron therapy may include constipation, diarrhea, dark stools and abdominal pain. Excessive amount of calcium salts may lead to hypercalcemia. Hypermagnesaemia is uncommon after oral administration of magnesium salts except in the presence of renal impairment Due to excessive potassium, it may lead to the development of hyperkalaemia, especially in patients with renal impairment.



Eginvit should not be used in pregnancy because of the ginseng constituent, which was found to cause foetal abnormalities in early stages of pregnancy. There was no human studies on the safety of ginseng in Eginvit capsule, but only in vitro studies in animal studies reported minimal risk. Therefore, it should not be used in breastfeeding.



All ingestions require supportive management and an intravenous line. Serious ingestions require hydration if vomiting or diarrhea in present. Oxygen, monitoring, and ABCs are essential if potentially life-threatening manifestations are present.
If potentially lethal coingestions are present, perform gastric lavage if the patient presents within 1 hour postingestion. Always check whether the vitamin overdose included iron supplements, and manage such an overdose aggressively.



Store in a cool place.

Protect from light.

Keep all medicines away from the reach of children.



10 capsules packed in a blister and such 3 blisters are packed in a carton.


Marketed by

JB Pharmaceutical Ltd, 400, Commercial Avenue, Sabo Yaba, Lagos, Nigeria.


Manufactured under license with

Celogan Pharma Pvt. Ltd., Navi Mumbai, India.


Manufactured by

Olive Healthcare, 192/2, Athiawad, Dabhel Village, Daman, India.
NAFDAC Regn. No: A4-2863

Published by


I am a blogging and data enthusiast.